Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Reuters reports the unit received an NMPA drug supplementary application approval notice for leuprorelin acetate microspheres for injection 11.25mg (3-month formulation).
Shanghai Livzon received NMPA clearance to market leuprorelin acetate microspheres injection 11.25 mg, adding a three-month specification to its existing 3.75 mg and 1.88 mg versions. R&D spending for the three-month formulation was about RMB 94.0548 million.